IBDEI1NH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28009,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,28010,0)
 ;;=99211^^110^1398^1
 ;;^UTILITY(U,$J,358.3,28010,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,28010,1,1,0)
 ;;=1^NURSING VISIT
 ;;^UTILITY(U,$J,358.3,28010,1,2,0)
 ;;=2^99211
 ;;^UTILITY(U,$J,358.3,28011,0)
 ;;=J3420^^111^1399^7^^^^1
 ;;^UTILITY(U,$J,358.3,28011,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28011,1,2,0)
 ;;=2^J3420
 ;;^UTILITY(U,$J,358.3,28011,1,3,0)
 ;;=3^B12 INJ. UP TO 1,000MCG
 ;;^UTILITY(U,$J,358.3,28012,0)
 ;;=J0800^^111^1399^17^^^^1
 ;;^UTILITY(U,$J,358.3,28012,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28012,1,2,0)
 ;;=2^J0800
 ;;^UTILITY(U,$J,358.3,28012,1,3,0)
 ;;=3^CORTISON INJ, UP TO 40U
 ;;^UTILITY(U,$J,358.3,28013,0)
 ;;=J1631^^111^1399^32^^^^1
 ;;^UTILITY(U,$J,358.3,28013,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28013,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,28013,1,3,0)
 ;;=3^HALDOL 50MG
 ;;^UTILITY(U,$J,358.3,28014,0)
 ;;=J2680^^111^1399^72^^^^1
 ;;^UTILITY(U,$J,358.3,28014,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28014,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,28014,1,3,0)
 ;;=3^PROLIXIN INJ UP TO 25MG
 ;;^UTILITY(U,$J,358.3,28015,0)
 ;;=J1630^^111^1399^33^^^^1
 ;;^UTILITY(U,$J,358.3,28015,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28015,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,28015,1,3,0)
 ;;=3^HALDOL 5MG
 ;;^UTILITY(U,$J,358.3,28016,0)
 ;;=J9202^^111^1399^86^^^^1
 ;;^UTILITY(U,$J,358.3,28016,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28016,1,2,0)
 ;;=2^J9202
 ;;^UTILITY(U,$J,358.3,28016,1,3,0)
 ;;=3^ZOLADEX 3.6MG
 ;;^UTILITY(U,$J,358.3,28017,0)
 ;;=J0885^^111^1399^22^^^^1
 ;;^UTILITY(U,$J,358.3,28017,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28017,1,2,0)
 ;;=2^J0885
 ;;^UTILITY(U,$J,358.3,28017,1,3,0)
 ;;=3^EPOGEN INJ, NON-ESRD 1000 UNITS
 ;;^UTILITY(U,$J,358.3,28018,0)
 ;;=J0881^^111^1399^6^^^^1
 ;;^UTILITY(U,$J,358.3,28018,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28018,1,2,0)
 ;;=2^J0881
 ;;^UTILITY(U,$J,358.3,28018,1,3,0)
 ;;=3^ARANESP (NON-ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,28019,0)
 ;;=J0882^^111^1399^5^^^^1
 ;;^UTILITY(U,$J,358.3,28019,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28019,1,2,0)
 ;;=2^J0882
 ;;^UTILITY(U,$J,358.3,28019,1,3,0)
 ;;=3^ARANESP (ESRD) 1MCG
 ;;^UTILITY(U,$J,358.3,28020,0)
 ;;=J1826^^111^1399^38^^^^1
 ;;^UTILITY(U,$J,358.3,28020,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28020,1,2,0)
 ;;=2^J1826
 ;;^UTILITY(U,$J,358.3,28020,1,3,0)
 ;;=3^INTERFERON BETA-1A 30mcg
 ;;^UTILITY(U,$J,358.3,28021,0)
 ;;=J9217^^111^1399^48^^^^1
 ;;^UTILITY(U,$J,358.3,28021,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28021,1,2,0)
 ;;=2^J9217
 ;;^UTILITY(U,$J,358.3,28021,1,3,0)
 ;;=3^LEUPROLIDE INJ 7.5MG
 ;;^UTILITY(U,$J,358.3,28022,0)
 ;;=J9218^^111^1399^46^^^^1
 ;;^UTILITY(U,$J,358.3,28022,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28022,1,2,0)
 ;;=2^J9218
 ;;^UTILITY(U,$J,358.3,28022,1,3,0)
 ;;=3^LEUPROLIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,28023,0)
 ;;=J1950^^111^1399^47^^^^1
 ;;^UTILITY(U,$J,358.3,28023,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28023,1,2,0)
 ;;=2^J1950
 ;;^UTILITY(U,$J,358.3,28023,1,3,0)
 ;;=3^LEUPROLIDE INJ 3.75MG
 ;;^UTILITY(U,$J,358.3,28024,0)
 ;;=J9219^^111^1399^45^^^^1
 ;;^UTILITY(U,$J,358.3,28024,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28024,1,2,0)
 ;;=2^J9219
 ;;^UTILITY(U,$J,358.3,28024,1,3,0)
 ;;=3^LEUPROLIDE IMPLANT 65MG
 ;;^UTILITY(U,$J,358.3,28025,0)
 ;;=J0696^^111^1399^79^^^^1
 ;;^UTILITY(U,$J,358.3,28025,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,28025,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,28025,1,3,0)
 ;;=3^ROCEPHIN INJ-250MG
